Observational studyPediatric research2026
Pulmonary comorbidities and response to surfactant in late preterm infants: a multicenter cohort study.
Observational study in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Surfactant replacement therapy in late preterm respiratory disease: Identifying suitable candidates.Pediatric research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurfactant (SRT) therapy is well-established for respiratory distress syndrome (RDS) in very preterm infants, but its effectiveness in late preterms (≥ 34 weeks' gestation) is less defined. We evaluated post-SRT oxygenation responses in late preterm infants in relation to pulmonary comorbidities.
methodsIn this multicenter prospective cohort, 350 late preterm infants received SRT according to European RDS guidelines. Pulmonary comorbidities-including persistent pulmonary hypertension (PPHN), meconium aspiration, air leaks, pulmonary hemorrhage, and pneumonia-were documented. Oxygen saturation to inspired oxygen ratios (S/F ratios) were recorded over 48 h. A good response was defined as a ≥ 50% increase in the S/F ratio or an S/F ≥ 428 (SpO₂ ≥90% in room air) at 6 h post-treatment.
resultsSixty-four percent of infants demonstrated a good response; 81% of these maintained sustained improvement. In a mixed-effects model evaluating factors influencing post-SRT improvement in oxygenation, PPHN (p < 0.001) and air leaks (p = 0.001) were significantly associated with less improvement. Meconium aspiration (p = 0.066) and pulmonary hemorrhage (p = 0.100) showed a negative trend, whereas congenital pneumonia showed no association. Responders received SRT earlier than nonresponders (median 7.2 vs. 15.6 h; p = 0.003).
conclusionSurfactant improves oxygenation in late preterm infants, though response depends on timing and comorbidities. Suboptimal response may indicate PPHN. IMPACT: Surfactant therapy improves oxygenation in late preterm infants, but comorbidities such as PPHN and air leaks significantly reduce its effectiveness. Early administration is associated with a better response; treatment delays may contribute to poorer outcomes. Suboptimal response should prompt investigation for underlying conditions. Surfactant use should not be withheld solely based on gestational age.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.